• Global patent filings in cancer nanotechnology have surged, with China and the USA dominating innovation output.
• Drug delivery systems and photothermal therapy are the most active research hotspots, reflecting clinical translation priorities.
• The convergence of nanotechnology with immunotherapy and personalized medicine is a key emerging trend.
• Bibliometric insights guide strategic R&D investment and policy formulation in cancer nanotechnology.